We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Register to vote Register by 18 June to vote in the General Election on 4 July.
TACO is one of the most common causes of transfusion-related deaths in the UK and cases have increased substantially in recent years. Identifying risk factors for TACO prior to transfusion allows initiation of appropriate mitigating measures.
How to use a before-and-after study to evaluate your digital health product.
Advice and guidance on the health needs of migrant patients from Bulgaria for healthcare practitioners.
Advice and guidance on the health needs of migrant patients from the Czech Republic for healthcare practitioners.
A summary of recent letters and notifications sent to healthcare professionals about medicines and medical devices, and information about the publication of two recent Device Safety Information pages. The article also includes information on a recent National Patient Safety Alert...
Change your protocol, update your authorisation, report safety issues, submit safety updates and complete your end-of-trial study report.
Advice and guidance on the health needs of migrant patients from Jamaica for healthcare practitioners.
Information about incidents and outbreaks of Ebola and Marburg, both viral haemorrhagic fevers (VHF).
This guidance informs stakeholders about upcoming introductions to the Restricted Patient System.
Advice and guidance on the health needs of migrant patients for healthcare practitioners.
Advice and guidance on the health needs of migrant patients from Indonesia for healthcare practitioners.
Advice and guidance on the health needs of migrant patients from China for healthcare practitioners.
Background information and advice on coronavirus (COVID-19) for health and care professionals.
The Medicines and Healthcare products Regulatory Agency (MHRA) has today (11 March 2024) approved the medicine quizartinib (Vanflyta) to be used alongside chemotherapy as first line treatment for adults who have acute myeloid leukaemia (AML).
Advice and guidance on the health needs of migrant patients from Laos for healthcare practitioners.
Advice and guidance on the health needs of migrant patients from Papua New Guinea for healthcare practitioners.
Advice and guidance on the health needs of migrant patients from Nigeria for healthcare practitioners.
Advice and guidance on the health needs of migrant patients from Saint Lucia for healthcare practitioners.
Advice and guidance on the health needs of migrant patients from Jordan for healthcare practitioners.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).